SVWA
AMGN icon

Sarver Vrooman Wealth Advisors’s Amgen AMGN Stock Holding History

Sarver Vrooman Wealth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Sell
284
-3
-1% -$1.03K 0.06% 30
2026
Q1 		$101K Hold
287
– – 0.06% 29
2025
Q4 		$93.9K Sell
287
-80
-22% -$25.4K 0.06% 29
2025
Q3 		$104K Hold
367
– – 0.07% 28
2025
Q2 		$102K Sell
367
-51
-12% -$14.4K 0.07% 23
2025
Q1 		$130K Buy
+418
New +$123K 0.09% 16

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Sarver Vrooman Wealth Advisors's AMGN Position: Q2 2026 in Review

Sarver Vrooman Wealth Advisors reduced its Amgen (AMGN) stake by 1% in Q2 2026, selling an estimated $1.03K and leaving 284 shares worth $105K. The position accounts for 0.06% of the portfolio, ranked #30.

Sarver Vrooman Wealth Advisors first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $130K in Q1 2025. 836 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sarver Vrooman Wealth Advisors held 284 shares of Amgen worth $105K as of Q2 2026.
  • Sarver Vrooman Wealth Advisors sold 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.06% of Sarver Vrooman Wealth Advisors's portfolio in Q2 2026, its #30 holding.
  • Sarver Vrooman Wealth Advisors first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Sarver Vrooman Wealth Advisors's Amgen position peaked at $130K in Q1 2025.
  • 836 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sarver Vrooman Wealth Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.